Regulatory Guidance
AAPS-FDA Drug Transporters
- Regulatory Guidance
- May 30, 2018
- Greg Loewen, Michael Millhollen
The American Association of Pharmaceutical Scientists (AAPS) and U.S. Food and Drug Administration (FDA) co-sponsored the workshop “Drug Transporters in ADME:...
In Vitro DDI Regulatory Guidance Reference Poster
- Regulatory Guidance
- May 29, 2018
- Michael Millhollen
At the 2018 Marbach Castle Drug-Drug Interaction Workshop in Germany, Dr. Brian Ogilvie, Vice President of Scientific Consulting, presented a comparison...
Initial Impressions of New Draft FDA DDI Guidance Documents from XenoTech
- Regulatory Guidance
- October 26, 2017
- Michael Millhollen, Dr. Brian Ogilvie
Updated Nov. 6th, 2017 The FDA has released its long-awaited new draft guidance for industry on drug-drug interaction (DDI) studies....
Considerations In Response to Drug-Drug Interaction Guidances
- Regulatory Guidance
- August 17, 2017
- Michael Millhollen
Check out the recent IQ consortium publication: Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidances from...
Navigating the Transporter Wave of 2013
- Regulatory Guidance
- August 28, 2013
- Greg Loewen
The International Transporter Consortium (ITC) issued 7 papers in the July 2013 issue of Clinical Pharmacology & Therapeutics. These 7...
Subscribe to our Newsletter
Stay up to date with our news, events and research
Do you have a question or a request for upcoming blog content?
We love to get your feedback